New York, March 13, 2018:

    Bioabsorbable Stent/Bioresorbable Scaffold Market Forecast 2018 to 2023

    The Bioabsorbable Stent/Bioresorbable Scaffold Market is expected to exceed more than US$ 462.87 Million by 2023 at a CAGR of 11% in the given forecast period.

    The scope of the report includes a detailed study of Bioabsorbable Stent/Bioresorbable Scaffold Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Browse Full Report @:

    The Bioabsorbable Stent/Bioresorbable Scaffold Market has been segmented as below:

    By Application Type:

    • Coronary Artery Diseases
    • Peripheral Artery Diseases

    By Material type:

    • Bioresorbable polymer based stents
    • Bioresorbable metallic stents

    By Absorption Type:

    • Slow- absorption stents
    • Fast- absorption stents

    By End Consumers:

    • Hospitals
    • Cardiac Centers

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    This report provides:

    1) An overview of the global market for Bioabsorbable Stent/Bioresorbable Scaffold Market.
    2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Bioabsorbable Stent/Bioresorbable Scaffold Market

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Allergy Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    Request Sample Report:


    Table of Contents

    1 Introduction

    2 Market Research Tactics

    3 Market Summary

    4 Quality Market Insights

    5 Market Bioresorbable Stents Market Overview

    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers Rapidly Growing Geriatric Population And Increased Risk Of Cad And Pad In The Elderly Strong Product Pipeline
    5.2.2 Restraints Presence Of Substitutes
    5.2.3 Opportunities

    5.2.4 Challenges

    6 Regulatory Market Synopsis

    7 Bioresorbable Stents Market, By Application

    8 Bioresorbable Stents Market, By Absorption Rate

    9 Bioresorbable Stents Market, By Material

    10 Bioresorbable Stents Market, By End Consumer

    11 Bioresorbable Stents Market, By Geographic Region

    12 Competitive Landscape

    13 Company Profiles

    13.1 Abbott

    13.2 Reva Medical, Inc.

    13.3 Elixir Medical Corporation

    13.4 Kyoto Medical Planning  Co., Ltd.

    13.5 Biotronik

    13.6 Amaranth Medical, Inc.

    13.7 Arterial Remodeling Technologies

    13.8 Meril Life Sciences Pvt. Ltd.

    13.9 Arterius Limited

    13.10 Lepu Medical Technology Co., Ltd.

    13.11 Boston Scientific Corporation

    13.12 480 Biomedical

    13.13 S3v Vascular Technologies Private Limited

    13.14 Qualimed (Part Of Q3 Medical Group)

    13.15 Orbusneich



    Media Contact


    Company Name: Market Research Engine

    Contact Person: John Bay


    Phone: +1-855-984-1862

    Country: United States